Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950156-13-000080
Filing Date
2013-11-14
Accepted
2013-11-14 12:40:18
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 BODY OF FORM 10-Q d902089_igi10q.htm 10-Q 314765
2 EXHIBIT 31.1 ex311_902089.htm EX-31 6773
3 EXHIBIT 31.2 ex312_902089.htm EX-31 6743
4 EXHIBIT 32.1 ex321_902089.htm EX-32 3592
5 EXHIBIT 32.2 ex322_902089.htm EX-32 3589
  Complete submission text file 0000950156-13-000080.txt   4086255

Data Files

Seq Description Document Type Size
6 ig-20130930.xml EX-101.INS 633839
7 ig-20130930.xsd EX-101.SCH 39181
8 ig-20130930_cal.xml EX-101.CAL 21099
9 ig-20130930_def.xml EX-101.DEF 184583
10 ig-20130930_lab.xml EX-101.LAB 295346
11 ig-20130930_pre.xml EX-101.PRE 189805
Mailing Address 105 LINCOLN AVENUE BUENA NJ 08310
Business Address 105 LINCOLN AVENUE BUENA NJ 08310 6096971441
IGI LABORATORIES, INC (Filer) CIK: 0000352998 (see all company filings)

EIN.: 010355758 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-08568 | Film No.: 131218242
SIC: 2836 Biological Products, (No Diagnostic Substances)